Folotyn Infusion
Pralatrexate
20mg/ml
MUNDIPHARMA MEDICAL COMPANY
| Pack size | 1 Ampoule |
|---|---|
| Dispensing mode | POM |
| Source | SWITZERLAND |
| Agent | CITY MEDICAL STORE |
| Retail Price | 18076.50 AED |
Indications
Folotyn Infusion is used for:
Treatment of relapsed or refractory peripheral T-cell lymphoma.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Pralatrexate :
Mechanism of Action
The selectivity of pralatrexate for cancer cells is based upon the observation that cancer cells generally have an overexpression of reduced folate carrier protein-1 (RTC-1) compared to normal somatic cells. This carrier protein allows the entrance of pralatrexate into the cell. Upon entering the cell, folypolyglutamate synthase FPGS catalyzes the polyglutamination of pralatrexate so that it is retained inside the cell.
Once inside, pralatrexate competitively inhibits dihydrofolate reductase (DHFR) and thymidylate synthase. Subsequent depletion of thymidine monophosphate (TMP) occurs so that the cancer cell is unable to synthesize DNA and RNA. As a result, the cancer cell cannot proliferate and is forced to undergo apoptosis. Pralatrexate is more effective against cells that are actively dividing.
Note
Folotyn 20mg/ml Infusion manufactured by MUNDIPHARMA MEDICAL COMPANY. Its generic name is Pralatrexate. Folotyn is availble in United Arab Emirates.
Farmaco UAE drug index information on Folotyn Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.